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Háttér és célkitûzés – Az intraventricularis subependy-
momák ritka, jóindulatú daganatok, amelyeket gyakran
tévesen ependymomáknak diagnosztizálnak. Áttekintettük a
subependymomák klinikopatológiai jellemzôit.
Betegek kiválasztása és módszerek – Az intraventricularis
subependymomák retrospektív klinikai elemzése és a szövet-
tani metszetek szisztematikus áttekintése a központunkban
1985 és 2005 között operált betegek anyagaiból.
Eredmények – Összesen 20 subependymomás beteget
kezeltünk, medián életkoruk 50 év volt (19–77 év). Két
daganat (10%) a III., három (15%) a IV. és 15 az oldalkam-
rákban volt található. Több beteg volt férfi (12 vs. 8). A leg-
gyakoribb klinikai tünet az ataxia (n=13) és a papillaoede-
ma (n=7) volt. Nagy totális reszekció történt 15 esetben, öt
esetben szubtotális reszekció. Egyik esetben sem észleltünk
mitotikus mintázatot, vascularis endothelialis proliferációt
vagy nekrózist. A sejtproliferációs marker MIB-1 aktivitása (a
pozitívan festôdô tumorsejtek százalékos aránya) 0–1,4%
között változott (átlag 0,3). Két beteg részesült preoperatív
sugárkezelésben (50 Gy) a CT-korszak elôtt, három másik
beteg posztoperatív sugárkezelést kapott a szövettanilag ere-
detileg differenciált ependymomának diagnosztizált tumor-
ra. Három beteg (15%) mûtéti szövôdmény miatt meghalt a
mûtét után 1–3 hónappal, három beteget független ok miatt
veszítettünk el a 8., 26. és 110. hónapban. Összesen 15
beteg volt életben a tízéves követés végére a tumorrecidíva
jele nélkül.
Következtetés – A subependymomák differenciált laesiók, a
betegek jó állapotban maradnak adjuváns sugárkezelés
nélkül is. Sejtdús területbôl vett kis mintákból tévesen diffe-
renciált ependymomát diagnosztizálhatnak, amit szükségte-
len sugárkezelés követhet. A recidívák, a gyors ütemû
növekedés szövettani felülvizsgálatot tesz szükségessé, mivel
az ependymomák sejtszegény területei is zavart okozhatnak.
Kulcsszavak: subependymoma, mûtét, sugárkezelés, 
prognosztikai faktorok
Background and purpose – Intraventricular subependy-
momas are rare benign tumors, which are often misdiag-
nosed as ependymomas. To review the clinicopathological
features of subependymomas.
Patient selection and methods – Retrospective clinical
analysis of intraventricular subependymomas and systematic
review of histological slides operated on at our center
between 1985 and 2005.
Results – Twenty subependymomas presented at the median
age of 50 years (range 19-77). Two (10%) were found in the
third, three (15%) in the forth, and 15 in the lateral ventri-
cles. There was male preponderance (12 vs. 8). Ataxia
(n=13) and papilledema (n=7) were the most common clin-
ical presentations. Fifteen patients underwent gross total
resection, and five had subtotal resection. None of the cases
showed mitotic figures, vascular endothelial proliferation or
necrosis. Cell proliferation marker MIB-1 activity (percentage
of positive staining tumor cells) ranged from 0 to 1.4%
(mean 0.3). Two cases were treated with preoperative radia-
tion therapy (50 Gy) before the CT era, three other patients
received postoperative radiation therapy for tumors original-
ly diagnosed histologically as low grade ependymomas.
Three patients (15%) died of surgical complication between
one and three months postoperatively, and three patients
died of unrelated causes in eight, 26 and 110 months.
Fifteen patients were alive without evidence of tumor recur-
rence at a median follow-up time of 10 years.
Conclusion – Subependymomas are low-grade lesions and
patients do well without adjuvant radiotherapy. Small sam-
ples from more cellular areas may be confused with low
grade ependymomas, and unnecessary radiotherapy may
follow. Recurrences, rapid growth rates should warrant histo-
logical review, as hypocellular areas of ependymomas may
also be a source of confusion.
Keywords: subependymoma, surgery, radiotherapy, 
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Subependymoma was first described as a sepa-rate entity by Sheinker in 19451. It is a slow
growing benign neoplasm with male predominance,
typically attached to the wall of lateral or fourth
ventricles. Various estimates put the incidence of
subependymomas between 0.2% and 0.7% of all
brain tumors2 and approximately 100 cases were
reported until 20053, 4. According to the literature,
more than half of them are incidentally found at
autopsy in the middle-aged or elderly and sympto-
matic cases requiring surgical intervention account
for 37% of all cases5.
Subependymomas are of benign character with
favorable prognosis although the histology some-
times may reveal atypical, large and polymorphous
nuclei6. The benign nature of this entity is con-
firmed by low MIB-1 labeling indices7 and diploid
patterns8.
According to some investigators mitoses and
patchy necroses may occur. However, these are
rather considered as the mixture of ependymomas
and subependymomas9, blurring of higher grade
lesions to the scope of this very distinct low grade
entity. In the present paper we review the clinico-
pathological features of subependymomas at our
institute, focusing on the possible effect of adjuvant
radiation therapy (RT) in the misdiagnosed cases.
Materials and methods
PATIENT CHARACTERISTICS
Twenty consecutive patients (12 males and eight
females) were identified and approved by review
board of our institution as subependymoma based
on systematic review of histological slides of intra-
ventricular tumors operated on at our center
between 1985 and 2005. The median age at opera-
tion was 50 years (range 19–77). The majority of
the tumors were located in the frontal horns, three
in the forth and two in the third ventricles. While
typically large tumors were found in the lateral ven-
tricles, mostly small tumors were located to the
fourth ventricle, and subependymomas in the third
ventricle were rare.
DIAGNOSIS AND TREATMENT
CT was performed in 11, MRI in nine, and carotid
angiography in four patients. Extent of surgery was
assessed by postoperative CT scans and operational
notes, classified as subtotal (< 90% of tumor bulk
resected), or gross total resection.
The available original histological slides were
reviewed and paraffin blocks were recut for MIB-1
staining (Dako, 1:250). Histological review reclas-
sified two subependymomas to ependymomas, and
three ependymomas to subependymomas.
RT was given prior to surgery and definitive his-
tological diagnosis in two cases, and three patients
received RT within six weeks after surgery (these
were the cases that were initially classified as
ependymomas, and reclassified after our histo -
pathological review as subependymomas). The
median dose of radiation was 54 Gy (range 50-60)
administered over 5-6 weeks using conventional
fractionation (2 Gy/day). Irradiation was given via
two lateral opposed telecobalt or 6-9 MV photon
beam with a margin of 2-3 cm.
FOLLOW-UP AND DATA ANALYSIS
Patients were checked annually, more frequently if
clinically indicated. Survival was calculated from
the date of surgery to the time of death, or to the
time of preparation of the manuscript. The median
follow-up time of the 15 long surviving patients
from tissue diagnosis to the last known status was
10 years (range 6-24). The clinical, radiological,
histological, and treatment parameters and follow-
up information were analyzed, supplemented by
medical record review and contacting the patients,
if needed. 
Results
STATISTICAL DATA
Gross total surgical removal was achieved in 15 and
subtotal in five patients. Some degree of contrast
enhancement on the post-operative CT scan was
observed in eight cases.
There were three (15%) postoperative deaths.
Two patients died of concomitant diseases (leu -
kaemia and liver cancer) in 26 and eight months,
and one patient died of cardiac failure at 110
months, all others were disease free at the time of
preparation of manuscript (Figure 1.).
CLINICAL DATA
The subjective complaints and clinical symptoms
in all patients were very similar to that of ependy-
momas. Duration of complaints took generally less
than 12 months, but one patient had epileptic
seizures for 15 years. Headaches, nausea and vom-
iting only occurred during the last 3-4 months.
Signs of increased intracranial pressure as head -
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aches, mental impairment and drowsiness were fre-
quent. The clinical features are summarized in
Table 1.
All tumors were verified by contrast enhanced
CT and/or MRI investigations. In 13 cases lesion
was hypodense/hypointense and in seven cases
hyperdense/hyperintense, and contrast enhance-
ment occurred in eight cases. Cystic degeneration
was seen in three, and calcification was observed in
one case (Figure 2.). Carotid and vertebral angiog-
raphy were performed in four patients and showed
slightly vascular mass. However, it was insufficient
for proper differential diagnosis.
Most tumors were found in the frontal horns,
three of them partly extended into the third ventri-
cle and one up to the trigonal region with small
satellites on the ventricle wall. Concomitant hydro-
cephalus was characteristic in all but one cases due
to obstruction of the CSF pathway. 
Surgical removal of the supratentorial tumors
was performed mostly through transcortical-
transsulcal, and only once through parasagittal tran-
scallosal approach. The third ventricle tumor
removal was performed through supracerebellar
approach. The tumors localized in the fourth ventri-
cle was operated using suboccipital approach.
Tumors appeared as gray-white, smooth surfaced,
hard, rubbery hypovascular masses, although two
tumors were moderately vascular.
Five patients received conventional radiothera-
py. Two of them were investigated at our institute
before the CT era. Both tumors were diagnosed by
pneumoencephalography and angiography as
bifrontal tumors involving the corpus callosum and
were considered inoperable. RT had been applied
to both patients, but proved to be ineffective. They
were reinvestigated two and three years later due to
disease progression and proper diagnosis was made
by CT and these intraventricular, relatively circum-
scribed masses were operated on. Both tumors were
large (6×6 and 4×5 cm), occupying the frontal horn.
One of them extended into the trigonal region, infil-
trating the white mater, and was accompanied by
small satellite lesions on the ipsilateral lateral ven-
tricle wall. Both of these patients died of surgical
complications at one and two months following sur-
gery. 
HISTOLOGICAL DATA
Microscopic examination showed predominantly
low cellularity with alternating clustering of cells
with acellullar, fibrillar matrix with microcysts.
Tumor nuclei were small, round to ovoid, with
indistinct cytoplasmic borders. Rosenthal fibers and
eosinophil granular inclusions were noted in 4/20
cases (Figure 3.).
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Figure 1. Kaplan-Meier survival curve of our series
Table 1. Clinical features of subependymomas
Figure 2. Subependymoma on T1-wighted MR image
(left-sided photo): isointense tumor with mild contrast
enhancement showing cystic degeneration. On T2-
weighted MR image (right-sided photo): heterogenity
due to blood products, calcification and cystic changes
with hyperintense tumor mass
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Focal areas of higher cellularity showing mild
nuclear pleimorphism were noted in 3/20 cases.
Neither mitotic activity nor necrosis were observed
in any of the cases, and MIB-1 activity was gener-
ally below 1% (Figure 4.), reaching 3% only in the
cellular areas of the above mentioned three cases.
Dilated, thin-walled, cavernous vascular channels,
reminiscent of vascular malformations were embed-
ded within the tumor tissue in two of the cases.
Discussion
The intraventricular localization of subependymo-
mas renders radiographic diagnosis relatively
easy10. CT typically demonstrates a solid, hypo-
dense lesion and the rare contrast enhancement is
focal or irregular at best. However, marked, inho-
mogenous enhancement have been found in some
posterior fossa tumors11. MRI characteristics are
similar, nearly always hypo- or isointense lesions
on Tl-weighted, and occasionally hyperintense on
T2-weighted images. Contrast enhancement is rare.
Cystic forms, some degree of calcification occur
sporadically in individual cases (Figure 2.). The
tumors are usually lobulated and sharply demarcat-
ed from the surroundings2, 6, 12. Tumor specific pre-
operative diagnosis is complicated by similar pres-
entation of various intraventricular tumors, e.g.
neurocytomas and especially low grade ependymo-
mas2, 13. It has been emphasized by some authors14,
15 that the lack of contrast enhancement could dis-
tinguish them from other lateral ventricle tumors.
However, low grade ependymomas and neurocy-
tomas do not necessarily enhance, while in our
series eight subependymomas showed foci of en -
hancement.
Similarly, there are no characteristic clinical
symptoms: the signs of increased intracranial pres-
sure are dominating in most cases including
papilledema, mental disturbances and eventually 6th
nerve palsy. Focal neurological signs are rare as
well as preoperative epileptic fits in the history of
these tumors12. Subarachnoid hemorrhage may also
be the first clinical sign in exceptional cases16–18.
Subependymomas are more often found
between the fourth and sixth decades of life7 but it
has been observed at any age group. Interestingly,
half of the symptomatic subependymomas was
younger than 40 years of age in our material. There
is slight male preponderance, the male to female
ratio being nine to seven, which is similar to our
material (12 to eight). Perioperative mortality is
infrequent. It mostly occurred among earlier cases,
before CT and microsurgical methods were intro-
duced1, 19. Ho wever, it has also been reported in
recent studies as well2, 20, mostly due to meningitis
or sepsis. Re currence of the tumor is extremely
rare. Although in one of our patients a recurrence
was initially considered, based on the review of
the operative notes and original films, the case is
best viewed as a large residuum requiring second
operation.
The benign nature of this entity was confirmed
by the low MIB-1 labeling indices5, 7 and by diploid
patterns8. Satellite lesions on the ventricular wall,
so called candle guttering, should not be confused
with true metastatic foci. According to some inves-
tigators, mitoses, patchy necroses may occur.
However, based on our experience, these are better
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Figure 3. Rosenthal fibers noted in one of our cases.
H&E staining, magnification 1:200
Figure 4. In the entire section only one core was posi-
tive. Ki-67/MIB-1 activity below 1%, strongly suggesting
low proliferating activity and benign nature of the lesion.
MIB-1 stain, magnification 1:250
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viewed as mixed ependymomas-subependymomas
rather than allowing the blurring of higher grade
lesions to the scope of this very distinct low grade
entity. 
The radiosensitivity of the tumor was mentioned
in some papers6, 8. Im et al.4 reported two patients
receiving radiosurgery, but in both cases tumors
recurred in short time. In our series of the five irra-
diated patients two were incorrectly diagnosed clin-
ically without histology, while three further cases
were considered low grade ependymomas original-
ly. Radiation therapy was without benefit in the lat-
ter group.
Conclusion
Subependymomas are low-grade lesions and pa -
tients do well without adjuvant therapy. 
Subependymomas are easily diagnosed with
either CT or MRI scans.
Radical surgical excision is the treatment of
choice when possible, as adjuvant therapy has little
or no effect on lesion control.
Recurrences or rapid growth rates should war-
rant histological review, as hypocellular areas of
ependymomas may be the source of diagnostic con-
fusion. 
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